Niagen Bioscience, Inc. held its 2026 Annual Meeting of Stockholders on June 24, 2026. The meeting included votes on the election of directors, ratification of the independent auditor, and advisory approval of executive compensation. All director nominees presented were elected to serve until the 2027 Annual Meeting. Crowe LLP was ratified as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The compensation paid to the company's named executive officers was approved on an advisory basis.